{
    "code": "02021195",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021195",
    "time": "2020-02-25 12:38:41",
    "許可證字號": "衛署藥輸字第021195號",
    "註銷狀態": "已註銷",
    "註銷日期": "103\/01\/28",
    "註銷理由": "未展延而逾期者",
    "有效日期": "90\/04\/11",
    "發證日期": "85\/04\/11",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202119502",
    "中文品名": "希利治林鹽酸鹽",
    "英文品名": "SELEGILINE HYDROCHLORIDE",
    "適應症": "巴金森病症之輔助治療劑",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "01製劑原料",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0801701100  東信化學藥品有限公司",
        "申請商地址": "台北市吉林路４５號６樓",
        "主製造廠": ""
    },
    "CCC號列": "29214900906 其他芳香族一元胺及其衍生物；其鹽類Other aromatic monoamines and their derivatives; salts thereof",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816401112",
            "成分名稱": "SELEGILINE HYDROCHLORIDE(DEPRENYL HYDROCHLORIDE)",
            "含量描述": "98.0-120.0",
            "含量": "",
            "單位": "%"
        }
    ]
}